Oncaspar Injection, Solution
Product Images NDC 72694-954

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oncaspar (NDC 72694-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Servier Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Oncaspar 01)

A scatter plot comparing asparagine concentration (µM) over days after the first dose of L-Asparaginase for two treatments: Native E. coli L-Asparaginase and Oncaspar. The y-axis shows asparagine levels on a logarithmic scale from 0.1 to 100 µM and the x-axis ranges from 0 to 30 days. Data points include error bars illustrating variability for each time point.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

The image shows the packaging label for ONCASPAR injection containing 750 International Units (iU) per mL of pegaspargase. The label indicates a 5 mL single-use vial for intravenous or intramuscular use, made by Servier Pharmaceuticals LLC. It includes dosage instructions, storage conditions, active and inactive ingredient details, trademark and manufacturing information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.